Calcium and Vitamin D Intakes in Children

Sponsor
Federico II University (Other)
Overall Status
Completed
CT.gov ID
NCT01638494
Collaborator
(none)
184
1
2

Study Details

Study Description

Brief Summary

Calcium (Ca2+) and vitamin D (VitD) play an important role in child health. Aims. The investigators evaluated the daily intake of Ca2+ and VitD in healthy children; and the efficacy of Ca2+ and VitD supplementation. Daily Ca2 + and VitD intake was evaluated in consecutive healthy children through a validated questionnaire. Subjects with a daily Ca2 + and VitD intake < 70% of dietary reference intakes (DRIs) were invited to participate in prospective randomized trial with 2 groups of nutritional intervention: group 1, dietary counseling aiming to optimize daily Ca2+ and VitD intake plus administration of a commercially available Ca2 + and VitD supplementation product (Colecalcium®, Humana, Milan, Italy); group 2, dietary counseling alone. At the enrollment (T0) and after 4 months (T1) serum VitD levels were assessed.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Colecalcium supplement
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
184 participants
Intervention Model:
Factorial Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Study Start Date :
Dec 1, 2008
Actual Primary Completion Date :
Feb 1, 2009
Actual Study Completion Date :
Feb 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Experimental: Colecalcium testing

administration of Colecalcium

Dietary Supplement: Colecalcium supplement
Daily Ca2+ and VitD intake was determined using a previously validated written dietary questionnaire, filled by the parents with the help of a registered dietitian. Eventual assumption of Ca2+ and/or VitD supplements or fortified foods was also registered. All questionnaires were collected and analyzed using a specific software based on the Italian food composition tables (Winfood, Medimatica SRL, Martinsicuro, Teramo, Italy). All data were recorded in a specific clinical chart before statistical analysis. All subjects with less than 70% of the DRIs were invited to participate in a randomized trial aiming to investigate the efficacy of different nutritional interventions. The dietitian gave information to the parents on how to improve the consumption of foods rich in Ca2+ and VitD according to DRIs. No nutritional support products were prescribed in children enrolled in group 2.

Outcome Measures

Primary Outcome Measures

  1. Assessed VitD intake in a population of healthy pediatric subjects and evaluate the efficacy and applicability of a nutritional intervention to optimize VitD intake. [about 1 year]

    Evaluation and treatment of children with hypocalcemia and hypovitaminosis D.

Secondary Outcome Measures

  1. Assessed Ca2 intake in a population of healthy pediatric subjects and evaluate the efficacy and applicability of a nutritional intervention to optimize Ca2 intake. [about 1 year]

    Evaluation and treatment of children with hypocalcemia and hypovitaminosis D.

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ambulatory healthy subjects (male and female, age range 3-17 years) consecutively observed at our Department for routine clinical examination because vaccination program were considered eligible for the study.

Exclusion criteria

  • malnutrition (defined as a weight/height ratio <5° centile);

  • presence of chronic systemic diseases (celiac disease, inflammatory bowel disease, food allergy, cystic fibrosis, malignancy, immunodeficiency, tuberculosis, genetic-metabolic disease, primitive bone disease, diabetes and endocrine disorder);

  • and use of systemic steroids in the previous 3 months.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Federico II University

Investigators

  • Principal Investigator: Roberto Berni Canani, MD, PhD, Federico II University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Roberto Berni Canani, MD, PhD, Federico II University
ClinicalTrials.gov Identifier:
NCT01638494
Other Study ID Numbers:
  • 56/09
First Posted:
Jul 11, 2012
Last Update Posted:
Jul 11, 2012
Last Verified:
Jul 1, 2012
Keywords provided by Roberto Berni Canani, MD, PhD, Federico II University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2012